Statistics

Total Visits

	Views
Efectividad y riesgos del tratamiento biológico con Natalizumab en esclerosis múltiple	742

File Visits

	Downloads
TFG-M-M1037.pdf	393
TFG-M-M1037-ANEXO.pdf	175

Select a period of time:

ViewsDownloads

Number of views in the range

	Views
Efectividad y riesgos del tratamiento biológico con Natalizumab en esclerosis múltiple	176

Number of downloads in the range

	Downloads
TFG-M-M1037.pdf	31
TFG-M-M1037-ANEXO.pdf	17

Views

	Views
August 2025	13
September 2025	15
October 2025	31
November 2025	48
December 2025	20
January 2026	44
February 2026	5

Download CSV file

Bar graph

Line graph

Number of downloads in the period of time

Downloads
August 2025

3
September 2025

9
October 2025

3
November 2025

10
December 2025

10
January 2026

9
February 2026

4
Download CSV file

Bar graph

Line graph

Top country views

	Views
United States	64
Spain	25
China	17
Brazil	14
Belgium	8
Hong Kong	6
Vietnam	5
Germany	3
France	3
United Kingdom	3

Top countries by downloads

	Downloads
United States	8
China	7
Spain	6
Hong Kong	2
Germany	1
France	1
United Kingdom	1

Top cities views

	Views
Inca	8
Dallas	8
Los Angeles	7
Madrid	6
Central	6
Brussels	5
Valladolid	4
São Paulo	3
Caracas	3
Beijing	2

Top cities by downloads

	Downloads
Los Angeles	3
Inca	2
Central	2
Madrid	1
Beijing	1